These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30145124)

  • 1. Abnormalities on structural MRI associate with faster disease progression in multiple system atrophy.
    Krismer F; Seppi K; Wenning GK; Papapetropoulos S; Abler V; Goebel G; Schocke M; Poewe W
    Parkinsonism Relat Disord; 2019 Jan; 58():23-27. PubMed ID: 30145124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of rasagiline in patients with the parkinsonian variant of multiple system atrophy: a randomised, placebo-controlled trial.
    Poewe W; Seppi K; Fitzer-Attas CJ; Wenning GK; Gilman S; Low PA; Giladi N; Barone P; Sampaio C; Eyal E; Rascol O;
    Lancet Neurol; 2015 Feb; 14(2):145-52. PubMed ID: 25498732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of multiple system atrophy (MSA): a prospective natural history study by the European MSA Study Group (EMSA SG).
    Geser F; Wenning GK; Seppi K; Stampfer-Kountchev M; Scherfler C; Sawires M; Frick C; Ndayisaba JP; Ulmer H; Pellecchia MT; Barone P; Kim HT; Hooker J; Quinn NP; Cardozo A; Tolosa E; Abele M; Klockgether T; Østergaard K; Dupont E; Schimke N; Eggert KM; Oertel W; Djaldetti R; Poewe W;
    Mov Disord; 2006 Feb; 21(2):179-86. PubMed ID: 16161136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of multiple system atrophy in the USA: a prospective cohort study.
    Low PA; Reich SG; Jankovic J; Shults CW; Stern MB; Novak P; Tanner CM; Gilman S; Marshall FJ; Wooten F; Racette B; Chelimsky T; Singer W; Sletten DM; Sandroni P; Mandrekar J
    Lancet Neurol; 2015 Jul; 14(7):710-9. PubMed ID: 26025783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally clinically important decline in the parkinsonian variant of multiple system atrophy.
    Krismer F; Seppi K; Wenning GK; Abler V; Papapetropoulos S; Poewe W
    Mov Disord; 2016 Oct; 31(10):1577-1581. PubMed ID: 27474888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White Matter Abnormalities Track Disease Progression in Multiple System Atrophy.
    Raghavan S; Lesnick TG; Castillo AM; Reid RI; Fought AJ; Thostenson KB; Johnson Sparrman KL; Gehrking TL; Gehrking JA; Sletten DM; Low PA; Singer W; Vemuri P
    Mov Disord Clin Pract; 2024 Sep; 11(9):1085-1094. PubMed ID: 38923361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of multiple system atrophy: a prospective European cohort study.
    Wenning GK; Geser F; Krismer F; Seppi K; Duerr S; Boesch S; Köllensperger M; Goebel G; Pfeiffer KP; Barone P; Pellecchia MT; Quinn NP; Koukouni V; Fowler CJ; Schrag A; Mathias CJ; Giladi N; Gurevich T; Dupont E; Ostergaard K; Nilsson CF; Widner H; Oertel W; Eggert KM; Albanese A; del Sorbo F; Tolosa E; Cardozo A; Deuschl G; Hellriegel H; Klockgether T; Dodel R; Sampaio C; Coelho M; Djaldetti R; Melamed E; Gasser T; Kamm C; Meco G; Colosimo C; Rascol O; Meissner WG; Tison F; Poewe W;
    Lancet Neurol; 2013 Mar; 12(3):264-74. PubMed ID: 23391524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The European Multiple System Atrophy-Study Group (EMSA-SG).
    Geser F; Seppi K; Stampfer-Kountchev M; Köllensperger M; Diem A; Ndayisaba JP; Ostergaard K; Dupont E; Cardozo A; Tolosa E; Abele M; Dodel R; Klockgether T; Ghorayeb I; Yekhlef F; Tison F; Daniels C; Kopper F; Deuschl G; Coelho M; Ferreira J; Rosa MM; Sampaio C; Bozi M; Schrag A; Hooker J; Kim H; Scaravilli T; Mathias CJ; Fowler C; Wood N; Quinn N; Widner H; Nilsson CF; Lindvall O; Schimke N; Eggert KM; Oertel W; del Sorbo F; Carella F; Albanese A; Pellecchia MT; Barone P; Djaldetti R; Meco G; Colosimo C; Gonzalez-Mandly A; Berciano J; Gurevich T; Giladi N; Galitzky M; Ory F; Rascol O; Kamm C; Buerk K; Maass S; Gasser T; Poewe W; Wenning GK;
    J Neural Transm (Vienna); 2005 Dec; 112(12):1677-86. PubMed ID: 16049636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of mesenchymal stem cells in multiple system atrophy.
    Lee PH; Lee JE; Kim HS; Song SK; Lee HS; Nam HS; Cheong JW; Jeong Y; Park HJ; Kim DJ; Nam CM; Lee JD; Kim HO; Sohn YH
    Ann Neurol; 2012 Jul; 72(1):32-40. PubMed ID: 22829267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study.
    Foubert-Samier A; Pavy-Le Traon A; Guillet F; Le-Goff M; Helmer C; Tison F; Rascol O; Proust-Lima C; Meissner WG
    Neurobiol Dis; 2020 Jun; 139():104813. PubMed ID: 32087288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment and structural brain damage in multiple system atrophy-parkinsonian variant.
    Caso F; Canu E; Lukic MJ; Petrovic IN; Fontana A; Nikolic I; Kostic VS; Filippi M; Agosta F
    J Neurol; 2020 Jan; 267(1):87-94. PubMed ID: 31559533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial.
    Rascol O; Cochen de Cock V; Pavy-Le Traon A; Foubert-Samier A; Thalamas C; Sommet A; Rousseau V; Perez-Lloret S; Fabbri M; Azulay JP; Corvol JC; Couratier P; Damier P; Defebvre L; Durif F; Geny C; Houeto JL; Remy P; Tranchant C; Verin M; Tison F; Meissner WG;
    Mov Disord; 2021 Jul; 36(7):1704-1711. PubMed ID: 33792958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11)C] (R)-PK11195 PET (MEMSA-trial).
    Dodel R; Spottke A; Gerhard A; Reuss A; Reinecker S; Schimke N; Trenkwalder C; Sixel-Döring F; Herting B; Kamm C; Gasser T; Sawires M; Geser F; Köllensperger M; Seppi K; Kloss M; Krause M; Daniels C; Deuschl G; Böttger S; Naumann M; Lipp A; Gruber D; Kupsch A; Du Y; Turkheimer F; Brooks DJ; Klockgether T; Poewe W; Wenning G; Schade-Brittinger C; Oertel WH; Eggert K
    Mov Disord; 2010 Jan; 25(1):97-107. PubMed ID: 20014118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of subcortical atrophy and iron deposition in multiple system atrophy: a comparison between clinical subtypes.
    Lee JH; Kim TH; Mun CW; Kim TH; Han YH
    J Neurol; 2015 Aug; 262(8):1876-82. PubMed ID: 26016683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Different Symptom Assessment Scales for Multiple System Atrophy.
    Matsushima M; Yabe I; Oba K; Sakushima K; Mito Y; Takei A; Houzen H; Tsuzaka K; Yoshida K; Maruo Y; Sasaki H
    Cerebellum; 2016 Apr; 15(2):190-200. PubMed ID: 26093615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR Inhibition with Sirolimus in Multiple System Atrophy: A Randomized, Double-Blind, Placebo-Controlled Futility Trial and 1-Year Biomarker Longitudinal Analysis.
    Palma JA; Martinez J; Millar Vernetti P; Ma T; Perez MA; Zhong J; Qian Y; Dutta S; Maina KN; Siddique I; Bitan G; Ades-Aron B; Shepherd TM; Kang UJ; Kaufmann H
    Mov Disord; 2022 Apr; 37(4):778-789. PubMed ID: 35040506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered structural connectivity of the motor subnetwork in multiple system atrophy with cerebellar features.
    Shah A; Prasad S; Rastogi B; Dash S; Saini J; Pal PK; Ingalhalikar M
    Eur Radiol; 2019 Jun; 29(6):2783-2791. PubMed ID: 30552481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of dysautonomia in multiple system atrophy: a prospective study of self-perceived impairment.
    Köllensperger M; Stampfer-Kountchev M; Seppi K; Geser F; Frick C; Del Sorbo F; Albanese A; Gurevich T; Giladi N; Djaldetti R; Schrag A; Low PA; Mathias CJ; Poewe W; Wenning GK
    Eur J Neurol; 2007 Jan; 14(1):66-72. PubMed ID: 17222116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease.
    Barbagallo G; Sierra-Peña M; Nemmi F; Traon AP; Meissner WG; Rascol O; Péran P
    Mov Disord; 2016 Mar; 31(3):325-34. PubMed ID: 26676922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of parkinsonism in multiple system atrophy.
    Seppi K; Yekhlef F; Diem A; Luginger Wolf E; Mueller J; Tison F; Quinn NP; Poewe W; Wenning GK
    J Neurol; 2005 Jan; 252(1):91-6. PubMed ID: 15654560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.